rAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 5, 2011, Pages 496-504

  Zhang, Jingyu ^a,b   Yu, Zhigang ^b   Yu, Zhiqiang ^c   Yang, Zichao ^a   Zhao, Hong ^a   Liu, Luran ^a   Zhao, Jiexu ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

Brain derived neurotrophic factor; Gene therapy; Recombinant adeno associated virus; Stroke

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; NEUROPROTECTIVE AGENT;

ADENO ASSOCIATED VIRUS; ANIMAL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL CULTURE; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; MALE; METHODOLOGY; NERVE DEGENERATION; NEURITE; PATHOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TRANSGENE;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CELLS, CULTURED; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MALE; NERVE DEGENERATION; NEURITES; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TRANSGENES;

EID: 80055030268     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hennigan A, O'Callaghan RM and Kelly AM. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem Soc Trans 2007; 35: 424-427.
2. Vicario-Abejon C, Owens D, McKay R and Segal M. Role of neurotrophins in central synapse formation and stabilization. Nat Rev Neurosci 2002; 3: 965-974.
3. Beck T, Lindholm D, Castren E and Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J Cereb Blood Flow Metab 1994; 14: 689-692.
4. Varon S and Conner JM. Nerve growth factor in CNS repair. J Neurotrauma 1994; 11: 473-486.
5. Hetman M, Kanning K, Cavanaugh JE and Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signalregulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 1999; 274: 22569-22580.
6. Rossler OG, Giehl KM and Thiel G. Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: role of extracellular signalregulated protein kinase and phosphatidylinositol 3-kinase. J Neurochem 2004; 88: 1240-1252.
7. Skaper SD, Negro A, Facci L and Dal Toso R. Brain-derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5-trihydroxyphenylalanine-induced injury. J Neurosci Res 1993; 34: 478-487.
8. Almli CR, Levy TJ, Han BH, Shah AR, Gidday JM and Holtzman DM. BDNF protects against spatial memory deficits following neonatal hypoxiaischemia. Exp Neurol 2000; 166: 99-114.
9. Gobbo OL and O'Mara SM. Exercise, but not environmental enrichment, improves learning after kainic acid-induced hippocampal neurodegeneration in association with an increase in brain-derived neurotrophic factor. Behav Brain Res 2005; 159: 21-26.
10. Ferrer I, Ballabriga J, Marti E, Perez E, Alberch J and Arenas E. BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia. Brain Pathol 1998; 8: 253-261.
11. Han BH and Holtzman DM. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000; 20: 5775-5781.
12. Tandon P, Yang Y, Das K, Holmes GL and Stafstrom CE. Neuroprotective effects of brainderived neurotrophic factor in seizures during development. Neuroscience 1999; 91: 293-303.
13. Arai S, Kinouchi H, Akabane A, Owada Y, Kamii H, Kawase M and Yoshimoto T. Induction of brain-derived neurotrophic factor (BDNF) and the receptor trk B mRNA following middle cerebral artery occlusion in rat. Neurosci Lett 1996; 211: 57-60.
14. Schabitz WR, Schwab S, Spranger M and Hacke W. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1997; 17: 500-506.
15. Schabitz WR, Steigleder T, Cooper-Kuhn CM, Schwab S, Sommer C, Schneider A and Kuhn HG. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 2007; 38: 2165-2172.
16. Shirakura M, Inoue M, Fujikawa S, Washizawa K, Komaba S, Maeda M, Watabe K, Yoshikawa Y and Hasegawa M. Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils. Gene Ther 2004; 11: 784-790.
17. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I and Hamada H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 2004; 9: 189-197.
18. Klugmann M, Leichtlein CB, Symes CW, Klaussner BC, Brooks AI, Young D and During MJ. A novel role of circadian transcription factor DBP in hippocampal plasticity. Mol Cell Neurosci 2006; 31: 303-314.
19. Klugmann M, Leichtlein CB, Symes CW, Serikawa T, Young D and During MJ. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Mol Ther 2005; 11: 745-753.
20. Hauck B, Chen L and Xiao W. Generation and characterization of chimeric recombinant AAV vectors. Mol Ther 2003; 7: 419-425.
21. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL and During MJ. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
22. Longa EZ, Weinstein PR, Carlson S and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
23. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E and Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101: 593-600.
24. Ganz W, Watanabe I, Kanamasa K, Yano J, Han DS and Fishbein MC. Does reperfusion extend necrosis? A study in a single territory of myocardial ischemia--half reperfused and half not reperfused. Circulation 1990; 82: 1020-1033.
25. Zheng J, Shen WH, Lu TJ, Zhou Y, Chen Q, Wang Z, Xiang T, Zhu YC, Zhang C, Duan S and Xiong ZQ. Clathrin-dependent endocytosis is required for TrkB-dependent Akt-mediated neuronal protection and dendritic growth. J Biol Chem 2008;
26. Takano M, Horie H, Iijima Y, Dezawa M, Sawada H and Ishikawa Y. Brain-derived neurotrophic factor enhances neurite regeneration from retinal ganglion cells in aged human retina in vitro. Exp Eye Res 2002; 74: 319-323.
27. Davies AM, Thoenen H and Barde YA. The response of chick sensory neurons to brainderived neurotrophic factor. J Neurosci 1986; 6: 1897-1904.
28. Iwasaki K, Isaacs KR and Jacobowitz DM. Brainderived neurotrophic factor stimulates neurite outgrowth in a calretinin-enriched neuronal culture system. Int J Dev Neurosci 1998; 16: 135-145.
29. Blackledge G, Averbuch S, Kay A and Barton J. Anti-EGF receptor therapy. Prostate Cancer Prostatic Dis 2000; 3: 296-302.
30. Anido J, Matar P, Albanell J, Guzman M, Rojo F, Arribas J, Averbuch S and Baselga J. ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/ HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. Clin Cancer Res 2003; 9: 1274-1283.
31. Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK and Myers JN. Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res 2004; 10: 8594-8602.
32. Bull Phelps SL, Schorge JO, Peyton MJ, Shigematsu H, Xiang LL, Miller DS and Lea JS. Implications of EGFR inhibition in ovarian cancer cell proliferation. Gynecol Oncol 2008.